Concomitant chemoradiotherapy with cisplatin and docetaxel followed by surgery and consolidation chemotherapy in patients with unresectable locally advanced non-small cell lung cancer

Medical Oncology

Volumn 27, Issue 1, 2010, Pages 152-157

  Kaya, Ali Osman ^a   Buyukberber, Suleyman ^a   Benekli, Mustafa ^a   Coskun, Ugur ^a   Sevinc, Alper ^b   Akmansu, Muge ^a   Yildiz, Ramazan ^a   Ozturk, Banu ^a   Yaman, Emel ^a   Kalender, Mehmet Emin ^b   Orhan, Okan ^c   Yamac, Deniz ^a   Uner, Aytug ^a  

^a GAZI UNIVERSITY   (Turkey)

^b GAZIANTEP UNIVERSITY   (Turkey)

^c ERCIYES UNIVERSITY   (Turkey)

Author keywords

Concomitant chemoradiation; Locally advanced stage; Non small cell lung cancer; Surgery

Indexed keywords

CISPLATIN; DOCETAXEL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; ESOPHAGITIS; FEMALE; FOLLOW UP; HUMAN; INFECTION; LIVER TOXICITY; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NAUSEA AND VOMITING; NEUROPATHY; NEUTROPENIA; OVERALL SURVIVAL; PERICARDIAL EFFUSION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PNEUMONECTOMY; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY DOSAGE; TAXOIDS; TREATMENT OUTCOME;

EID: 77949269618     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9186-z     Document Type: Article

References (22)

1. Non-Small Cell Lung Cancer Collaborative Group 1995 Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials BMJ 311 899 909
2. K Furuse, et al. 1999 Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer J Clin Oncol 17 2692 2699 1:CAS:528:DyaK1MXmtlWru74%3D 10561343
3. WJ Curran, et al. 2003 Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemoradiation for patients with unresected stage III NSCLC: RTOG 9410 Proc Am Soc Clin Oncol 22 121 (Abstract 2499)
4. K Kiura, et al. 2003 Phase I/II study docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small cell lung cancer Br J Cancer 89 795 802 10.1038/sj.bjc.6601217 1:CAS:528: DC%2BD3sXms1Gku74%3D 12942107 (Pubitemid 37175797)
5. KS Albain, et al. 2005 Phase III study of concurrent chemotherapy, radiotherapy (CT/RT) versus CT/RT followed by surgical resection for stage IIIA (pN2) non-small-cell lung cancer: outcomes update of North Amrica Interfgroup 0139 (RTOG 9309) J Clin Oncol 23 7014
6. YC Ahn, et al. 2001 Preoperative concurrent chemoradiotherapy for stage IIIA non-small cell lung cancer Acta Oncol 40 588 592 10.1080/028418601750444123 1:STN:280:DC%2BD3Mrms1eqtg%3D%3D 11669330 (Pubitemid 32912436)
7. G Stamatis, et al. 1999 Preoperative chemoradiotherapy and surgery for selected non-small cell lung cancer IIIB subgroups: long-term results Ann Thorac Surg 68 1144 1149 10.1016/S0003-4975(99)00976-5 1:STN:280: DC%2BD3c%2FgvVyitw%3D%3D 10543470
8. H Katayama, et al. 2004 Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small cell lung cancer Br J Cancer 90 979 984 10.1038/sj.bjc.6601624 1:CAS:528: DC%2BD2cXhslWrsL0%3D 14997193 (Pubitemid 38495815)
9. MJ Edelman, et al. 2008 Phase I/II trial of hyperfractionated radiation and chemotherapy followed by surgery in stage III lung cancer Ann Thorac Surg 86 903 911 10.1016/j.athoracsur.2008.06.022 18721580
10. S-P Yap, et al. 2008 Induction concurrent chemoradiotherapy using paclitaxel and carboplatin combination followed by surgery in locoregionally advanced non-small cell lung cancer-Asian experience Ann Acad Med Singapore 37 377 382 18536823
11. M Thomas, et al. 2008 Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer Lancet Oncol 9 636 648 10.1016/S1470-2045(08)70156-6 18583190
12. B Kaplan, et al. 2004 Preliminary results of a phase II study of weekly paclitaxel (PTX) and carboplatin (CBDCA) administered concurrently with thoracic radiation therapy (TRT) followed by consolidation chemotherapy with PTX/CBDCA for stage III unresectable non-small-cell lung cancer (NSCLC) Am J Clin Oncol 27 603 610 10.1097/01.coc.0000135739.37072.ff 1:CAS:528:DC%2BD2MXjslKhtw%3D%3D 15577439 (Pubitemid 39603276)
13. CP Belani, et al. 2005 Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small cell lung cancer: a randomized phase II locally advanced multi-modality protocol J Clin Oncol 23 5883 5893 10.1200/JCO.2005.55.405 1:CAS:528:DC%2BD2MXhtVKgtbzM 16087941 (Pubitemid 46300204)
14. A Hurria MG Kris 2005 Management of lung cancer in older adults CA Cancer J Clin 53 325 341 10.3322/canjclin.53.6.325
15. National Cancer InstItute-Common Toxicity Criteria (NCI-CTC). NCI-CTC version 2.0, January 30; 1998
16. P Therasse EA Eisenhauer J Verveij 2006 RECIST revisited: a review of validation studies on tumor assessment Eur J Cancer 42 1031 1039 10.1016/j.ejca.2006.01.026 1:STN:280:DC%2BD283nt1antQ%3D%3D 16616487
17. EL Kaplan P Meier 1958 Nonparametric estimation from incomplete observations J Am Stat Assoc 53 457 481 10.2307/2281868
18. P Fournel, et al. 2005 Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancerologie NPC95-01 Study J Clin Oncol 23 5910 5917 10.1200/JCO.2005.03.070 1:CAS:528:DC%2BD2MXhtVKgtbzP 16087956 (Pubitemid 46300207)
19. T Le Chevalier, et al. 1994 Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbin alone in advanced non-small cell lung cancer: results of European multicenter trial including 612 patients J Clin Oncol 12 360 367 1:STN:280:DyaK2c7lslKitw%3D%3D 8113844
20. P Bonomi, et al. 2000 Comparison of survival and wuality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group Trial J Clin Oncol 18 623 631 1:CAS:528:DC%2BD3cXht1Kmtb0%3D 10653877
21. R Mudad, et al. 2003 Concomitant weekly docetaxel, cisplatin and radiation therapy in locally advanced non-small cell lung cancer: a dose finding study Lung Cancer 39 173 177 10.1016/S0169-5002(02)00448-8 12581570 (Pubitemid 36173618)
22. H-G Wu, et al. 2002 Phase I study of weekly docetaxel and cisplatin concurrent with thoracic radiotherapy in stage III non- small cell lung cancer Int Radiat Oncol Biol Phys 52 75 80 1:CAS:528:DC%2BD38XltFSm